Reaction Details Report a problem with these data
Target
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
Ligand
BDBM289657
Substrate
n/a
Meas. Tech.
PDE1B Inhibitory Assay
Temperature
298.15±n/a K
IC50
<100±n/a nM
Comments
extracted
Citation
 Branstetter, B; Breitenbucher, J; Dyck, B; Gomez, L; Hudson, AR; Marrone, TJ; Peters, M; Vickers, T; Weinhouse, M Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones US Patent  US10105367 Publication Date 10/23/2018 
Target
Name:
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
Synonyms:
63 kDa Cam-PDE | Calcium/calmodulin-dependent 3 ,5 -cyclic nucleotide phosphodiesterase 1B | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Cam-PDE 1B | PDE1B | PDE1B1 | PDE1B_HUMAN | PDES1B | Phosphodiesterase 1B | Phosphodiesterase 1B (PDE1B1) | Phosphodiesterase Type 1 (PDE1B) | Phosphodiesterase, PDE1/PDE5
Type:
Enzyme
Mol. Mass.:
61366.51
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
536
Sequence:
MELSPRSPPEMLEESDCPSPLELKSAPSKKMWIKLRSLLRYMVKQLENGEINIEELKKNLEYTASLLEAVYIDETRQILDTEDELQELRSDAVPSEVRDWLASTFTQQARAKGRRAEEKPKFRSIVHAVQAGIFVERMFRRTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITNQMSIDELSPCEEEAPPSPAEDEHNQNGNLD
  
Inhibitor
Name:
BDBM289657
Synonyms:
6-(4-Methoxybenzyl)-9-(pyrimidin-2-ylmethyl)-6,8,9,10,11,12-hexahydro-5H-[1,2,4]triazolo[1¿,5¿:1',6]pyrimido[5',4':4,5]thieno[2,3-c]azepin-5-one | US10092575, Example 145 | US10376514, Example 145
Type:
Small organic molecule
Emp. Form.:
C24H23N7O2S
Mol. Mass.:
473.55
SMILES:
COc1ccc(Cn2c3sc4CN(Cc5ncccn5)CCCc4c3c3ncnn3c2=O)cc1
Structure:
Search PDB for entries with ligand similarity: